Compare TTEC & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTEC | CLNN |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | United States |
| Employees | 69400 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.0M | 57.4M |
| IPO Year | 1996 | 2021 |
| Metric | TTEC | CLNN |
|---|---|---|
| Price | $1.26 | $3.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | N/A | ★ $33.75 |
| AVG Volume (30 Days) | ★ 475.6K | 81.7K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,509,171,000.00 | $200,000.00 |
| Revenue This Year | N/A | $17.64 |
| Revenue Next Year | $0.10 | $19,516.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $1.27 | $3.48 |
| 52 Week High | $3.99 | $13.50 |
| Indicator | TTEC | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 28.99 | 32.81 |
| Support Level | N/A | N/A |
| Resistance Level | $2.49 | $4.70 |
| Average True Range (ATR) | 0.06 | 0.34 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 4.55 | 20.42 |
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.